THERAPEUTIC CLASS
Usefulness of carcinoembryonic antigen in the diagnosis of small cell lung cancer combined with adenocarcinoma
Small cell lung cancer (SCLC) includes pure SCLC and SCLC combined with other pathologies (C-SCLC). C-SCLC accounts for about 28% of all SCLCs subjected to surgical resection, but only about 1–3% of C-SCLCs are detected by biopsy. Since less than 5% of SCLC patients are eligible for surgery,
it is necessary to develop alternative methods for the detection of C-SCLC
No other version available